/* ---- Google Analytics Code Below */

Friday, November 18, 2022

Single Drop Blood Test on Smartphone

 Blood Testing streamlined

Blood Test Only Needs a Drop and a Smartphone for Results 

The tech shows promise, although user-friendly “single drop of blood” platforms are still a few years away by GREG GOTH   in IEEE Spectrum

University of Washington researchers have developed a new blood-clotting test that uses only a single drop of blood and a smartphone with a plastic attachment that holds a tiny cup [shown here] beneath the phone’s camera. This photo simulates how this system works; the “blood” shown here is not real.  

The phrase “from a single drop of blood” is full of both promise and peril for researchers trying to integrate clinical-quality medical testing technology with consumer devices like smartphones. While university researchers and commercial startups worldwide continue to introduce innovative new consumer-friendly takes on tests that have resided in laboratories for decades, the collective memory of the fraud perpetrated by those behind Theranos’s discredited blood-testing platform is still pervasive.

“What are you claiming from a single drop of blood?” says Shyamnath Gollakota, director of the mobile intelligence lab at the University of Washington’s Paul G. Allen School of Computer Science and Engineering. Gollakota and colleagues have developed a proof-of-concept test that is able to analyze how quickly a person’s blood clots using a single drop of blood by utilizing a smartphone’s camera, haptic motor, a small attached cup, and a floating piece of copper about the size of a ballpoint pen’s writing tip.

To activate the system, the user adds a drop of blood from a finger prick to a small cup attached to a bracket that fits over the phone. Then the phone’s motor shakes the cup while the camera monitors the movement of the copper particle, which slows down and eventually stops as the clot forms. To calculate the time it takes the blood to clot, the phone collects two time stamps. The first is when the user inserts the blood, and second is when the particle stops moving. The technology performed is in line with commercial coagulation tests in the original study (published in Nature Communications) in a medical facility; Gollakota’s team is now studying how it works in at-home environments. ... ' 


No comments: